National Incidence, Outcomes, and Management Strategies for Pre- and Post-Transplant Atrial Fibrillation in Heart Transplant Recipients.

Alexander K KariusAlice L ZhouJessica M RuckAllan B MassieDorry L SegevDavid SpraggAhmet Kılıç

Published in: medRxiv : the preprint server for health sciences (2024)

Atrial fibrillation should not deter heart transplantation in appropriate candidates, though cardiovascular and stroke risk adjustment may be warranted.Use of amiodarone at doses ≤ 200 mg/day is not associated with reduced survival in heart transplant recipients with pre-transplant atrial fibrillation.

Keyphrases

atrial fibrillation
oral anticoagulants
catheter ablation
left atrial
left atrial appendage
heart failure
direct oral anticoagulants
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle
mitral valve
acute coronary syndrome
glycemic control